Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8671 |
High Similarity |
NPD1653 |
Approved |
0.8182 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8151 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7986 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.797 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7956 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7862 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7852 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7806 |
Intermediate Similarity |
NPD919 |
Approved |
0.7803 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7801 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7794 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7794 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7746 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7746 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7698 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7638 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7586 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7564 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7556 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7534 |
Intermediate Similarity |
NPD2796 |
Approved |
0.75 |
Intermediate Similarity |
NPD1933 |
Approved |
0.75 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD5353 |
Approved |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7481 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7455 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7415 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.741 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7386 |
Intermediate Similarity |
NPD920 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.732 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7315 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7261 |
Intermediate Similarity |
NPD37 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7255 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2237 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6385 |
Approved |
0.719 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7183 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7178 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7169 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7163 |
Intermediate Similarity |
NPD4749 |
Approved |
0.716 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7132 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7111 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD228 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7083 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7055 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD290 |
Approved |
0.7042 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD5762 |
Approved |
0.702 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7 |
Intermediate Similarity |
NPD17 |
Approved |
0.7 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4585 |
Approved |
0.6993 |
Remote Similarity |
NPD8651 |
Approved |
0.6987 |
Remote Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD7095 |
Approved |
0.6986 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6974 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6032 |
Approved |
0.6944 |
Remote Similarity |
NPD1203 |
Approved |
0.6939 |
Remote Similarity |
NPD411 |
Approved |
0.6933 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6929 |
Remote Similarity |
NPD1357 |
Approved |
0.6928 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6923 |
Remote Similarity |
NPD2534 |
Approved |
0.6923 |
Remote Similarity |
NPD2533 |
Approved |
0.6923 |
Remote Similarity |
NPD2532 |
Approved |
0.6908 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD7644 |
Approved |
0.6906 |
Remote Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6887 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6875 |
Remote Similarity |
NPD2922 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6871
|
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |